Similar articles

• Labetalol in the treatment of a patient with phaechromocytoma: a case report.

  Bailey RR. Bailey RR. Br J Clin Pharmacol. 1979;8(Suppl 2):141S-142S. Br J Clin Pharmacol. 1979. PMID: 526394 Free PMC article. No abstract available.
• [Pheochromocytoma treated with combined alpha-beta blockader].

  Nyberg G, Waldenström J, Vedin A. Nyberg G, et al. Lakartidningen. 1979 Jun 6;76(23):2248-50. Lakartidningen. 1979. PMID: 459631 Swedish. No abstract available.
• [Clinical effects of labetalol on pheochromocytoma].

  Yoshinaga K, Arakawa K, Ando H, Iai F, Ikeda M. Yoshinaga K, et al. Horumon To Rinsho. 1983 Feb;31(2):183-92. Horumon To Rinsho. 1983. PMID: 6340865 Clinical Trial. Japanese. No abstract available.
• Labetalol and the management of hypertension.

  Reid JL, Meredith PA, Elliott HL. Reid JL, et al. J Cardiovasc Pharmacol. 1981;3 Suppl 1:S60-8. doi: 10.1097/00005344-198100031-00007. J Cardiovasc Pharmacol. 1981. PMID: 6169961 Review. No abstract available.
• Labetalol: a review of its pharmacology and therapeutic use in hypertension.

  Brogden RN, Heel RC, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1978 Apr;15(4):251-70. doi: 10.2165/00003495-197815040-00002. Drugs. 1978. PMID: 25757 Review.